Sanjay S. Shukla
2016
In 2016, Sanjay S. Shukla earned a total compensation of $1.1M as Chief Medical Officer at aTYR PHARMA.
Compensation breakdown
| Bonus | $31,250 |
|---|---|
| Non-Equity Incentive Plan | $87,750 |
| Option Awards | $612,872 |
| Salary | $284,135 |
| Other | $80,443 |
| Total | $1,096,450 |
Shukla received $612.9K in option awards, accounting for 56% of the total pay in 2016.
Shukla also received $31.3K in bonus, $87.8K in non-equity incentive plan, $284.1K in salary and $80.4K in other compensation.
Rankings
In 2016, Sanjay S. Shukla's compensation ranked 7,796th out of 14,075 executives tracked by ExecPay. In other words, Shukla earned more than 44.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,796 out of 14,075 | 45th |
Division Manufacturing | 2,965 out of 5,489 | 46th |
Major group Chemicals And Allied Products | 984 out of 1,895 | 48th |
Industry group Drugs | 763 out of 1,538 | 50th |
Industry Biological Products, Except Diagnostic Substances | 135 out of 279 | 52nd |
Source: SEC filing on March 30, 2017.
Shukla's colleagues
We found two more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2016.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019